113 related articles for article (PubMed ID: 21737344)
1. Alteration in surface muscle electrical anisotropy in the rat SOD1 model of amyotrophic lateral sclerosis.
Li J; Rutkove SB
Clin Neurophysiol; 2012 Jan; 123(1):206-10. PubMed ID: 21737344
[TBL] [Abstract][Full Text] [Related]
2. A technique for performing electrical impedance myography in the mouse hind limb: data in normal and ALS SOD1 G93A animals.
Li J; Staats WL; Spieker A; Sung M; Rutkove SB
PLoS One; 2012; 7(9):e45004. PubMed ID: 23028733
[TBL] [Abstract][Full Text] [Related]
3. Electrical impedance myography for monitoring motor neuron loss in the SOD1 G93A amyotrophic lateral sclerosis rat.
Wang LL; Spieker AJ; Li J; Rutkove SB
Clin Neurophysiol; 2011 Dec; 122(12):2505-11. PubMed ID: 21612980
[TBL] [Abstract][Full Text] [Related]
4. Progressive impairment of CaV1.1 function in the skeletal muscle of mice expressing a mutant type 1 Cu/Zn superoxide dismutase (G93A) linked to amyotrophic lateral sclerosis.
Beqollari D; Romberg CF; Dobrowolny G; Martini M; Voss AA; Musarò A; Bannister RA
Skelet Muscle; 2016; 6():24. PubMed ID: 27340545
[TBL] [Abstract][Full Text] [Related]
5. Different human copper-zinc superoxide dismutase mutants, SOD1G93A and SOD1H46R, exert distinct harmful effects on gross phenotype in mice.
Pan L; Yoshii Y; Otomo A; Ogawa H; Iwasaki Y; Shang HF; Hadano S
PLoS One; 2012; 7(3):e33409. PubMed ID: 22438926
[TBL] [Abstract][Full Text] [Related]
6. Delayed disease onset and extended survival in the SOD1G93A rat model of amyotrophic lateral sclerosis after suppression of mutant SOD1 in the motor cortex.
Thomsen GM; Gowing G; Latter J; Chen M; Vit JP; Staggenborg K; Avalos P; Alkaslasi M; Ferraiuolo L; Likhite S; Kaspar BK; Svendsen CN
J Neurosci; 2014 Nov; 34(47):15587-600. PubMed ID: 25411487
[TBL] [Abstract][Full Text] [Related]
7. The human G93A-SOD1 mutation in a pre-symptomatic rat model of amyotrophic lateral sclerosis increases the vulnerability to a mild spinal cord compression.
Jokic N; Yip PK; Michael-Titus A; Priestley JV; Malaspina A
BMC Genomics; 2010 Nov; 11():633. PubMed ID: 21078175
[TBL] [Abstract][Full Text] [Related]
8. Novel behavioural characteristics of the superoxide dismutase 1 G93A (SOD1
Kreilaus F; Guerra S; Masanetz R; Menne V; Yerbury J; Karl T
Genes Brain Behav; 2020 Feb; 19(2):e12604. PubMed ID: 31412164
[TBL] [Abstract][Full Text] [Related]
9. Amyloid precursor protein (APP) contributes to pathology in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
Bryson JB; Hobbs C; Parsons MJ; Bosch KD; Pandraud A; Walsh FS; Doherty P; Greensmith L
Hum Mol Genet; 2012 Sep; 21(17):3871-82. PubMed ID: 22678056
[TBL] [Abstract][Full Text] [Related]
10. Altered postnatal maturation of electrical properties in spinal motoneurons in a mouse model of amyotrophic lateral sclerosis.
Quinlan KA; Schuster JE; Fu R; Siddique T; Heckman CJ
J Physiol; 2011 May; 589(Pt 9):2245-60. PubMed ID: 21486770
[TBL] [Abstract][Full Text] [Related]
11. Gonadectomy and dehydroepiandrosterone (DHEA) do not modulate disease progression in the G93A mutant SOD1 rat model of amyotrophic lateral sclerosis.
Hayes-Punzo A; Mulcrone P; Meyer M; McHugh J; Svendsen CN; Suzuki M
Amyotroph Lateral Scler; 2012 May; 13(3):311-4. PubMed ID: 22409357
[TBL] [Abstract][Full Text] [Related]
12. MRI detects early hindlimb muscle atrophy in Gly93Ala superoxide dismutase-1 (G93A SOD1) transgenic mice, an animal model of familial amyotrophic lateral sclerosis.
Brooks KJ; Hill MD; Hockings PD; Reid DG
NMR Biomed; 2004 Feb; 17(1):28-32. PubMed ID: 15011248
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of Abeta is associated with acceleration of onset of motor impairment and superoxide dismutase 1 aggregation in an amyotrophic lateral sclerosis mouse model.
Li QX; Mok SS; Laughton KM; McLean CA; Volitakis I; Cherny RA; Cheung NS; White AR; Masters CL
Aging Cell; 2006 Apr; 5(2):153-65. PubMed ID: 16626394
[TBL] [Abstract][Full Text] [Related]
14. Pre-symptomatic detection of chronic motor deficits and genotype prediction in congenic B6.SOD1(G93A) ALS mouse model.
Hayworth CR; Gonzalez-Lima F
Neuroscience; 2009 Dec; 164(3):975-85. PubMed ID: 19699279
[TBL] [Abstract][Full Text] [Related]
15. The effect of peripheral nerve injury on disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
Sharp PS; Dick JR; Greensmith L
Neuroscience; 2005; 130(4):897-910. PubMed ID: 15652988
[TBL] [Abstract][Full Text] [Related]
16. Effects of diet on adenosine monophosphate-activated protein kinase activity and disease progression in an amyotrophic lateral sclerosis model.
Zhao Z; Sui Y; Gao W; Cai B; Fan D
J Int Med Res; 2015 Feb; 43(1):67-79. PubMed ID: 25534414
[TBL] [Abstract][Full Text] [Related]
17. Progressive Degeneration and Inhibition of Peripheral Nerve Regeneration in the SOD1-G93A Mouse Model of Amyotrophic Lateral Sclerosis.
Deng B; Lv W; Duan W; Liu Y; Li Z; Ma Y; Zhang G; Song X; Cui C; Qi X; Li Y; Li C
Cell Physiol Biochem; 2018; 46(6):2358-2372. PubMed ID: 29742495
[TBL] [Abstract][Full Text] [Related]
18. Neuromuscular accumulation of mutant superoxide dismutase 1 aggregates in a transgenic mouse model of familial amyotrophic lateral sclerosis.
Turner BJ; Lopes EC; Cheema SS
Neurosci Lett; 2003 Oct; 350(2):132-6. PubMed ID: 12972170
[TBL] [Abstract][Full Text] [Related]
19. Macrophage-mediated inflammation and glial response in the skeletal muscle of a rat model of familial amyotrophic lateral sclerosis (ALS).
Van Dyke JM; Smit-Oistad IM; Macrander C; Krakora D; Meyer MG; Suzuki M
Exp Neurol; 2016 Mar; 277():275-282. PubMed ID: 26775178
[TBL] [Abstract][Full Text] [Related]
20. Human neural stem cell replacement therapy for amyotrophic lateral sclerosis by spinal transplantation.
Hefferan MP; Galik J; Kakinohana O; Sekerkova G; Santucci C; Marsala S; Navarro R; Hruska-Plochan M; Johe K; Feldman E; Cleveland DW; Marsala M
PLoS One; 2012; 7(8):e42614. PubMed ID: 22916141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
